Malignant Mesothelioma Competitive Landscape Report 2021: 178 Drugs in the Pipeline with 84% Molecules Present in Early Stage Development
June 21, 2021 07:38 ET
|
Research and Markets
Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Malignant Mesothelioma - Competitive Landscape in 2021" report has been added to ResearchAndMarkets.com's offering. This reports provides a data-driven...
US Mesothelioma Market and Competitive Landscape Report 2021
May 28, 2021 08:48 ET
|
Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "US Mesothelioma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Mesothelioma Market and...
Global Mesothelioma Markets, Epidemiology and Patient Flow Report 2020-2035
May 18, 2021 05:43 ET
|
Research and Markets
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Global Mesothelioma Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global Mesothelioma Epidemiology...
Malignant Pleural Mesothelioma (MPM) Market Report 2020: Reduced Population-wide Exposure to Asbestos Lowering Incidence Rates of MPM
August 31, 2020 07:09 ET
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Malignant Pleural Mesothelioma (MPM) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The report delivers...